TCL Archive ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number June 17, 2011
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Funding Opportunities: RFA: Cancer Research Network Across Health Care Systems September 12, 1997